• Users Online: 325
  • Print this page
  • Email this page
Year : 2019  |  Volume : 5  |  Issue : 3  |  Page : 67-68

Metabolic implications of peritoneal dialysis

Department of Nephrology, Apollo Hospital, Chennai, Tamil Nadu, India

Correspondence Address:
Dr. K C Prakash
Apollo Hospital, Chennai, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jrnm.jrnm_61_19

Rights and Permissions

Peritoneal dialysis (PD) is a well-accepted form of renal replacement treatment. Glucose is the main agent used as an osmotic agent used in the majority of patients on PD. The other agents used are amino acid and polyglucose solutions in specific circumstances.[ Glucose loading is associated with certain downsides. Increase in plasma glucose leads to increased insulin secretion which leads to increased circulating insulin levels and hyperlipidemia and aggravate atherosclerosis. PD is associated with albumin and amino acid loss on a daily basis, which can be more in highly permeable peritoneal membrane or the presence of peritoneal inflammation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded168    
    Comments [Add]    

Recommend this journal